Pathology · Hematological Malignancies (Leukemias, Lymphomas, Myeloma)

Cytogenetic analysis of blasts from a 28-year-old adult with acute lymphoblastic leukemia identifies t(9;22)(q34;q11.2) with BCR-ABL1 fusion. Which statement about this finding is correct?

  • A It confers a favorable prognosis compared with hyperdiploidy in adult ALL
  • B It predicts response to all-trans retinoic acid combined with chemotherapy
  • C It carries a poor prognosis and usually involves the smaller p190 fusion protein
  • D It defines transformation of preexisting chronic myeloid leukemia and cannot arise de novo
Correct answer: C. It carries a poor prognosis and usually involves the smaller p190 fusion protein

Explanation

Philadelphia-positive ALL accounts for roughly 25% of adult ALL and carries one of the worst prognoses among ALL subgroups. In ALL the breakpoint is usually in the minor region producing the p190 BCR-ABL protein, unlike CML where p190 predominates only rarely and p210 is typical. Hyperdiploidy is favorable, ATRA targets PML-RARA, and although Ph-positive ALL can arise de novo, this case shows it does.

Reference: Robbins and Cotran Pathologic Basis of Disease, 10th ed.

High-yield for: NEET PGINI-CETNExTFMGEUSMLEPLABMRCP

Written and medically reviewed by the StethoPrep medical team.

Sponsored

Want to test yourself?

Create a free account for timed mock tests, mistake tracking, and FSRS spaced-repetition revision across 43,000+ MCQs.

Start free → Log in

More Hematological Malignancies (Leukemias, Lymphomas, Myeloma) MCQs

See all Hematological Malignancies (Leukemias, Lymphomas, Myeloma) MCQs →